Vociprotafib

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameVociprotafib
Drug Alias NameRMC-4630SAR-442720
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSrc homology phosphotyrosyl phosphatase 2 inhibitors
TargetsSrc homology phosphotyrosyl phosphatase 2
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[13] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofiRevolution Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesSanofiRevolution Medicines Inc
Inactive CompaniesThe Netherlands Cancer Institute
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsNeoplasm MetastasisPancreatic NeoplasmsColorectal Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A